850
Participants
Start Date
January 12, 2022
Primary Completion Date
February 21, 2023
Study Completion Date
February 21, 2023
V110
Single intramuscular (IM) dose of 0.5 mL V110, a pneumococcal polysaccharide vaccine (PCV), containing the 23 serotypes: 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F
V114
Single IM dose of 0.5 mL V114 a 15-valent PCV containing the 15 serotypes: 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, 33F
mRNA-1273
Single IM dose of 50 μg/0.25 mL mRNA-1273
Placebo for V110
Single IM dose of 0.5 mL placebo for V110
Placebo for V114
Single IM dose of 0.5 mL placebo for V114
Certified Research Associates ( Site 0042), Cortland
Rochester Clinical Research, Inc. ( Site 0010), Rochester
Corning Center for Clinical Research ( Site 0052), Horseheads
Centennial Medical Group ( Site 0016), Elkridge
Charlottesville Medical Research Center, LLC ( Site 0008), Charlottesville
Clinical Research Partners, LLC. ( Site 0005), Richmond
Alliance for Multispecialty Research LLC (AMR - Norfolk) ( Site 0057), Norfolk
Health Research of Hampton Roads, Inc. ( Site 0014), Newport News
Accellacare - Winston-Salem ( Site 0049), Winston-Salem
Coastal Carolina Research Center ( Site 0044), North Charleston
Atlanta Center For Medical Research ( Site 0053), Atlanta
Optimal Research LLC ( Site 0019), Melbourne
Indago Research and Health Center Inc ( Site 0006), Hialeah
Lakes Research LLC ( Site 0012), Miami Lakes
Alliance for Multispecialty Research, LLC ( Site 0036), Coral Gables
Advanced Medical Research, LLC ( Site 0030), Miami
AMR Lexington ( Site 0055), Lexington
Velocity Clinical Research- Cleveland ( Site 0023), Cleveland
Optimal Research ( Site 0054), Peoria
Alliance for Multispecialty Research, LLC ( Site 0011), Kansas City
Alliance for Multispecialty Research, LLC ( Site 0018), Newton
Wellness Clinical Research Associates ( Site 0051), McKinney
Benchmark Research ( Site 0039), Fort Worth
Texas Center For Drug Development ( Site 0013), Houston
DM Clinical Research ( Site 0025), Tomball
Crossroads Clinical Research LLC ( Site 0020), Victoria
Diagnostics Research Group ( Site 0001), San Antonio
South Texas Clinical Research ( Site 0033), Corpus Christi
Benchmark Research ( Site 0007), Austin
Velocity Clinical Research, Salt Lake City ( Site 0035), West Jordan
AXCES Research Group ( Site 0017), Santa Fe
Wake Research Clinical Research Center of Nevada, LLC ( Site 0021), Las Vegas
Center for Clinical Trials, LLC ( Site 0022), Paramount
Valley Clinical Trials Inc. ( Site 0002), Northridge
Carbon Health ( Site 0045), North Hollywood
Artemis Institute for Clinical Research ( Site 0024), San Diego
California Research Foundation ( Site 0004), San Diego
Millennium Clinical Trials ( Site 0027), Simi Valley
Diablo Clinical Research, Inc ( Site 0043), Walnut Creek
Community Clinical Research Center ( Site 0032), Marlborough
Velocity Clinical Research-Providence ( Site 0015), East Greenwich
University of Texas Medical Branch at Galveston ( Site 0037), Galveston
Cooperativa de Facultad Medica SANACOOP ( Site 0104), Bayamón
CAIMED Center - Ponce School of Medicine ( Site 0103), Ponce
Caparra Internal Medicine Research Center. PSC ( Site 0102), Río Grande
Clinical Research Puerto Rico ( Site 0105), San Juan
Merck Sharp & Dohme LLC
INDUSTRY